Rhenman & Partners Asset Management Ab Insmed Inc Transaction History
Rhenman & Partners Asset Management Ab
- $840 Million
- Q1 2025
A detailed history of Rhenman & Partners Asset Management Ab transactions in Insmed Inc stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 185,500 shares of INSM stock, worth $13.5 Million. This represents 1.68% of its overall portfolio holdings.
Number of Shares
185,500
Previous 61,500
201.63%
Holding current value
$13.5 Million
Previous $4.25 Million
233.36%
% of portfolio
1.68%
Previous 0.44%
Shares
4 transactions
Others Institutions Holding INSM
# of Institutions
489Shares Held
197MCall Options Held
892KPut Options Held
1.77M-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.33 Billion0.03% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y915.4MShares$1.12 Billion81.63% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.04 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.9MShares$940 Million0.12% of portfolio
-
Capital International Investors Los Angeles, CA7.2MShares$524 Million0.11% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.85B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...